Lavanya Ajay Sharma

Dr. Lavanya Ajay Sharma

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Seyed Ebrahim AlaviSeyed Ebrahim Alavi
Seyed Ebrahim Alavi
ARAun Raza
Aun Raza
MGMax Gholami
Max Gholami
MGMichael George Robinson Giles
Michael George Robinson Giles
RARayan Al-Sammak
Rayan Al-Sammak
LSLavanya Ajay Sharma
Lavanya Ajay Sharma
The oral cavity is a complex ecosystem accommodating various microorganisms (e.g., bacteria and fungi). Various factors, such as diet change and poor oral hygiene, can change the composition of oral microbiota, resulting in the dysbiosis of the oral micro-environment and the emergence of pathogenic microorganisms, and consequently, oral infectious diseases. Systemic administration is frequently used for drug delivery in the treatment of diseases and is associated with the problems, such as drug resistance and dysbiosis. To overcome these challenges, oral drug delivery systems (DDS) have received considerable attention. In this literature review, the related articles are identified, and their findings, in terms of current therapeutic challenges and the applications of DDSs, especially nanoscopic DDSs, for the treatment of oral infectious diseases are highlighted. DDSs are also discussed in terms of structures and therapeutic agents (e.g., antibiotics, antifungals, antiviral, and ions) that they deliver. In addition, strategies (e.g., theranostics, hydrogel, microparticle, strips/fibers, and pH-sensitive nanoparticles), which can improve the treatment outcome of these diseases, are highlighted.
1

1 May 2023 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
SASeyed Ebrahim Alavi
Seyed Ebrahim Alavi
SASeyed Zeinab Alavi
Seyed Zeinab Alavi
MGMax Gholami
Max Gholami
ASAjay Sharma
Ajay Sharma
LSLavanya Ajay Sharma
Lavanya Ajay Sharma
HSHasan Ebrahimi Shahmabadi
Hasan Ebrahimi Shahmabadi

25 July 2025 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
Seyed Ebrahim AlaviSeyed Ebrahim Alavi
Seyed Ebrahim Alavi
HSHasan Ebrahimi Shahmabadi
Hasan Ebrahimi Shahmabadi
LSLavanya Ajay Sharma
Lavanya Ajay Sharma
ASAjay Sharma
Ajay Sharma

1 March 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
SWShiromani Wijesundara
Shiromani Wijesundara
LSLavanya Ajay Sharma
Lavanya Ajay Sharma
Seyed Ebrahim AlaviSeyed Ebrahim Alavi
Seyed Ebrahim Alavi
ASAjay Sharma
Ajay Sharma
This study is a systematic review evaluating published literature on the effect of surgical treatments on peri-implantitis. Various databases were selected for the literature search on the topic. The considered primary clinical parameters were changes in probing pocket depth (PPD), bleeding on probing (BoP), radiographic bone change, plaque score, signs of infection, and implant loss. Five research studies comprising 20 or more sample sizes (patients) with minimal two-year follow-up after surgical treatment were selected, based on preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. In all five studies, PPD and BoP were significantly reduced compared to those before intervention. However, there was no significant variation in the patients treated with open flap debridement, citric acid decontamination, and subepithelial connective tissue graft. The highest reduction of BoP was recorded in the study utilizing regenerative surgical therapy, deproteinized bovine bone mineral containing 10% collagen, the derivative of enamel matrix, and doxycycline. According to the two–five-year follow-up of this systemic review, surgical treatment, including bone substitute material, showed clinical improvement in the reviewed studies, compared to that before intervention; however, there was no statistical significance in the clinical outcome of the selected studies.

1 February 2024 in Clinical and Experimental Dental Research
Verified
Journal Article
Open access
IWIngar Wong
Ingar Wong
ATAn Ton
An Ton
ACAmiel J. Cassidy
Amiel J. Cassidy
NFNicolette Fozzard
Nicolette Fozzard
LSLavanya Ajay Sharma
Lavanya Ajay Sharma
ASAjay Sharma
Ajay Sharma
Objectives: The objective of this retrospective study was to determine possible prognostic factors of endodontic‐periodontal lesions and to compare success, survival, and failure outcomes of treated endodontic‐periodontal lesions across different treatment modalities, demographic variables, and anatomical tooth variations.Materials and Methods: Data was collected from patient records in the patient management system (Salud, Titanium Solutions) from the Griffith University Dental Clinic between January 2008 and December 2021. The search strategy used the terms “endodontic periodontal lesion,” “periodontal endodontic lesion,” “endo perio lesion,” “perio endo lesion,” and “EPL.” The 88 cases which met inclusion and exclusion criteria were analyzed.Results: The overall success rate was 46.6%, with 21.6% of teeth surviving and 31.8% of teeth failing. Bone loss extending to the apical third (OR = 0.3, 95% CI [0.104, 0.866]), and probing depths of 5–7 mm (OR = 0.147, 95% CI [0.034, 0.633]) and 8‐10 mm (OR = 0.126, 95% CI [0.029, 0.542]) were associated with a statistically significant lower odds of success (p < .05). A history of no periodontal disease (OR = 7.705, 95% CI [1.603, 37.037]) was associated with a statistically significant higher odds of success (p < .05).Conclusion: Practitioners should be aware of bone loss to the apical third, deep probing depths, and a history of periodontal disease as possible prognostic factors that can affect the success rate when treating endodontic‐periodontal lesions. Further research with more stringent control over operator factors should be done to investigate these variables.

28 May 2025 in 3 Biotech
Verified
Journal Article
Open access
PDF file
WCWei-Ju Chen
Wei-Ju Chen
LSLavanya Ajay Sharma
Lavanya Ajay Sharma
PSPeng Shao
Peng Shao
TGTia Griffith
Tia Griffith
RLRobert Love
Robert Love
LSLavanya Ajay Sharma
Lavanya Ajay Sharma
This randomized double-blind placebo-controlled clinical trial aimed to evaluate the adjunctive use of Streptococcus salivarius M18 probiotic lozenges in the treatment of periodontitis. Following non-surgical periodontal therapy (NSPT), 55 participants with stage III or IV periodontitis were administered either S. salivarius M18 lozenges (test group) or a placebo for 12 weeks. Clinical assessments, including pocket probing depth (PPD), clinical attachment loss (CAL), bleeding on probing (BoP), and plaque index (PI), were performed at baseline (before treatment), immediately after treatment, and during post-treatment follow-ups at 12 and 24 weeks. Microbial analysis was conducted on the subgingival plaque samples collected. The test group demonstrated significantly improved PPD, BoP, and PI compared to the placebo group at post-treatment follow-ups, although no significant difference was observed in CAL. Microbiological analysis revealed a reduction in periodontal pathogens or a shift in the subgingival microbiota toward a decreased pathogenic profile in the test group. This trial is the first to demonstrate the safety and efficacy of S. salivarius M18 as an adjunctive treatment for periodontitis, supporting its potential for broader clinical use in managing periodontal health.